APMD · Apnimed, Inc. · Proposed Sales
$18.51
+1.92 (+11.54%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 8, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within the twelve months after the date that these consolidated financial statements are issued. The Company believes that its existing cash and cash equivalents of $172.8 million as of June 30, 2026, together with the additional proceeds received from the IPO, will be sufficient to allow the Company to fund operations at least twelve months from the date that the financial statements are issued.”View the 10-Q filed Sep 8, 2026
Market Cap
$771.42M
Shares
41.63M
Volume · Oct 20
311.11K
Avg daily vol (57 sessions)
525.16K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.